How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Chemicals and Materials · Forecast 2027–2033
Hexamethylenetetramine (HMTA) (CAS 100-97-0) Market
- By Application: Phenolic resin hardener, Pharmaceutical intermediate, Explosive manufacturing, Fuel tablets, Rubber vulcanization accelerator, Water treatment chemicals
- By Form: Powder, Granules, Solution
- By Purity Grade: Technical grade, Pharmaceutical grade, Food grade
- By End-Use Industry: Chemical manufacturing, Pharmaceuticals, Explosives and defense, Rubber and plastics, Water treatment, Food processing
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Phenolic resin hardener leads By Application at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 10 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
11 chapters · 266 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.63 →
- 10 Competitive Landscape 5 sections p.166 →
- 11 Company Profiles 10 players: SWOT & benchmarking p.174 →
Full report · locked preview
Everything inside the Hexamethylenetetramine (HMTA) (CAS 100-97-0) Market report
A complete, evidence-based study - 11 chapters and 111 sections covering market size, segmentation across 4 axes, regional analysis and 10 company profiles, forecast to 2033.
Segmentation covered
Application 6
Form 3
Purity Grade 3
End-Use Industry 6
Companies profiled
BASF SE
Hubei Xingfa Chemicals Group Co. Ltd.
Shandong Xinhua Pharmaceutical Company Limited
Jiangsu Sopo (Group) Co. Ltd.
Mitsubishi Gas Chemical Company Inc.
Zhejiang Juhua Co. Ltd.
Hebei Jinlong Chemical Co. Ltd.
Tianjin Bohai Chemical Industry Group Co. Ltd.
Lianyungang Huaxing Chemical Co. Ltd.
Changzhou Qianhong Chemical Co. Ltd.
Verified · Analyst-reviewed · No payment to preview
Trusted & certified by
★★★★★ Excellent
★★★★★ Excellent
10 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →BASF SE
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Hubei Xingfa Chemicals Group Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Shandong Xinhua Pharmaceutical Company Limited
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →Jiangsu Sopo (Group) Co. Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →Mitsubishi Gas Chemical Company Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.178 →Zhejiang Juhua Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.184 →Hebei Jinlong Chemical Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →Tianjin Bohai Chemical Industry Group Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Lianyungang Huaxing Chemical Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.202 →Changzhou Qianhong Chemical Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.209 →Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Global · 2025–2033
$1,084M by 2033 · 3.8% CAGR
Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Phenolic resin hardener45.7
- Pharmaceutical intermediate15.7
- Explosive manufacturing14.3
- Fuel tablets6.5
- Rubber vulcanization accelerator6.1
- Water treatment chemicals11.8
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →North America$265.4M → $353.7M · 3.7%
Europe$185.0M → $261.5M · 4.4%
Asia Pacific$168.9M → $245.4M · 4.8%
Latin America$104.5M → $150.6M · 4.7%
Middle East and Africa$80.4M → $96.9M · 2.4%
Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →3.772026
3.782027
3.792028
3.792029
3.802030
3.822031
3.832032
3.842033
CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- BASF SE18.2
- Hubei Xingfa Chemicals Group Co. Ltd.16.5
- Shandong Xinhua Pharmaceutical Company Limited9.6
- Jiangsu Sopo (Group) Co. Ltd.8.2
- Mitsubishi Gas Chemical Company Inc.9.8
- Zhejiang Juhua Co. Ltd.9.6
- Others28.1
Segment contribution to growth (%)
Fig. 18 · p.39 →Application22.4%
Form29.1%
Purity Grade29.0%
End-Use Industry19.5%
Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America31.9
- Europe23.6
- Asia Pacific22.2
- Latin America13.6
- Middle East and Africa8.7
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| BASF SE | 86 | 82 | 80 | 84 | 78 | 95 | 84 |
| Hubei Xingfa Chemicals Group Co. Ltd. | 76 | 75 | 93 | 82 | 90 | 78 | 82 |
| Shandong Xinhua Pharmaceutical Company Limited | 87 | 81 | 76 | 70 | 83 | 87 | 81 |
| Jiangsu Sopo (Group) Co. Ltd. | 60 | 76 | 74 | 74 | 64 | 75 | 71 |
| Mitsubishi Gas Chemical Company Inc. | 57 | 69 | 64 | 75 | 74 | 51 | 65 |
| Zhejiang Juhua Co. Ltd. | 64 | 53 | 52 | 57 | 56 | 51 | 56 |
| Hebei Jinlong Chemical Co. Ltd. | 65 | 60 | 46 | 54 | 57 | 56 | 56 |
| Tianjin Bohai Chemical Industry Group Co. Ltd. | 52 | 41 | 36 | 55 | 39 | 54 | 46 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- BASF SE
- Hubei Xingfa Chemicals Group Co. Ltd.
- Shandong Xinhua Pharmaceutical Company Limited
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| BASF SE | ✓ | ✓ | ◐ | ◐ | ◐ | ✓ |
| Hubei Xingfa Chemicals Group Co. Ltd. | ◐ | ✓ | ✓ | ✓ | ◐ | ✓ |
| Shandong Xinhua Pharmaceutical Company Limited | ✓ | ◐ | ✓ | ◐ | ◐ | ✓ |
| Jiangsu Sopo (Group) Co. Ltd. | − | ◐ | ◐ | ✓ | ◐ | ✓ |
| Mitsubishi Gas Chemical Company Inc. | − | ◐ | ◐ | ◐ | − | − |
| Zhejiang Juhua Co. Ltd. | ◐ | − | ◐ | − | ◐ | − |
| Hebei Jinlong Chemical Co. Ltd. | ✓ | − | − | ◐ | ◐ | − |
| Tianjin Bohai Chemical Industry Group Co. Ltd. | ◐ | − | − | ◐ | − | − |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →1BASF SE84
2Hubei Xingfa Chemicals Group Co. Ltd.82
3Shandong Xinhua Pharmaceutical Company Limited81
4Jiangsu Sopo (Group) Co. Ltd.71
5Mitsubishi Gas Chemical Company Inc.65
6Zhejiang Juhua Co. Ltd.56
7Hebei Jinlong Chemical Co. Ltd.56
8Tianjin Bohai Chemical Industry Group Co. Ltd.46
Competitive tiers
§8.4 · p.172 →Leader3
Set the pace on share, breadth and innovation.
BASF SEHubei Xingfa Chemicals Group Co. Ltd.Shandong Xinhua Pharmaceutical Company Limited
Challenger1
Strong scale, closing on the leaders.
Jiangsu Sopo (Group) Co. Ltd.
Contender1
Focused players with pockets of strength.
Mitsubishi Gas Chemical Company Inc.
Niche3
Specialists in a single segment or region.
Zhejiang Juhua Co. Ltd.Hebei Jinlong Chemical Co. Ltd.Tianjin Bohai Chemical Industry Group Co. Ltd.
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Go-to-market strategy
Land Application in North America, then scale across Hexamethylenetetramine (HMTA) (CAS 100-97-0) Market — a $582M beachhead inside a $9.91B market.
Beachhead (SOM)$582Mobtainable near-term
Serviceable (SAM)$3.39Breachable market
Primary motionPartner-led + digitalgo-to-market
Time to scale3 Qto full motion
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Champion89 fit
Phenolic resin hardener
Best fit — highest urgency & budget in Application.
Economic buyer75 fit
Pharmaceutical intermediate
Strong fit — clear ROI and a fast path to value.
End user65 fit
Explosive manufacturing
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Application in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Form & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Purity Grade
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Direct sales48%
Partner / channel26%
Digital / self-serve18%
Marketplaces8%
Positioning & messaging
§GTM 2 · p.194 →For Application leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Hexamethylenetetramine (HMTA) (CAS 100-97-0) Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Awareness100%
Marketing qualified45%
Sales qualified24%
Evaluation14%
Closed-won8%
$11.0KCAC
$50KLTV
4.6:1LTV : CAC
< 2 moCAC payback
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Investment thesis
Hexamethylenetetramine (HMTA) (CAS 100-97-0) Market is a durable-growth opportunity — $6.37B by 2033, compounding at 7.9%.
TAM · 2025$3.47Btoday
TAM · 2033$6.37Bforecast
CAGR7.9%2027–2033
Cumulative$43.1Brevenue opportunity
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →TAM$6.37BTotal addressable market
SAM$2.36BServiceable available market
SOM$480MServiceable obtainable market
Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →7.9% CAGR
Demand compounds through 2033, outpacing GDP across Application.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Application moving from early to mainstream — durable secular demand.
Consolidation upside
10+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →$6.37BLarge & growingTAM by 2033 at 7.9% CAGR
$2.36BServiceable nowreachable with today’s model
$480MBeachhead winobtainable near-term share
10+Fragmented fieldplayers — consolidation runway
Return scenarios (2033 market value)
Fig. 6 · p.22 →$4.97BBear5.1% CAGR
$6.37BBase7.9% CAGR
$8.15BBull10.4% CAGR
Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Form optionality
- Customer concentrationBroaden installed base beyond top accounts
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Board pack · executive summary
Hexamethylenetetramine (HMTA) (CAS 100-97-0) Market — a $6.84B market by 2033. Plan: grow share from 10.5% to 17.2%.
Market size · 2033$6.84Btotal addressable
Market CAGR3.5%2027–2033
Target share17.2%from 10.5% today
Revenue ambition$1.18Bby 2033
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.5% | 17.2% | On track |
| Revenue | $759M | $1.18B | Behind |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | Ahead |
| Segment coverage | 2 of 4 axes | 4 of 4 axes | On track |
| Gross margin | 31.1% | 39.3% | Ahead |
| Customer retention | 86.0% | 94.4% | Behind |
Where to play (strategic priorities)
§1.2 · p.8 →1
Lead segment
Win in Application
Largest revenue pool and fastest secular demand — concentrate to build share here first.
2
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
3
Adjacency
Build Form capability
A defensible second engine — invest in Form to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Application share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Form
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $130M capacity & capability investment
- Greenlight bolt-on M&A in Form
- Authorise North America expansion plan
- Fund R&D program for Application leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownOn track
- Competitive share lossOn track
- Input-cost & supply riskAhead
- Regulatory / policy changeAhead
- Execution & talentBehind
Values shown here are illustrative samples for your understanding — not exact figures. The full report contains the real, verified data.
Sales deck · value proposition
Win the Hexamethylenetetramine (HMTA) (CAS 100-97-0) Market conversation — a $7.07B market you can size, segment and defend in minutes.
Market size · 2033$7.07Btotal opportunity
Growth10.0%CAGR to 2033
Addressable buyers1,462+accounts in scope
Typical ROI4.3×in year one
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Application
Goal Grow share in Application
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →Decisions made on stale, generic dataLive, source-cited figures, continuously updated
Weeks waiting on a research vendorA full report compiled in minutes
No view of competitors or whitespaceCompany profiles, ACE matrix & benchmarking
Hard to defend the numbers internallyEvery figure traceable to its original source
The business case (ROI)
Fig. 2 · p.9 →4.3×return on cost, year one
< 3 mopayback period
$40K+research cost avoided
10×faster than a custom study
Time to insight
Cost to run
Risk of a wrong call
Why buyers trust it (proof points)
§1.3 · p.12 →600K+source studies indexed
100%analyst-reviewed
10+players profiled in this market
Coverage includes
BASF SEHubei Xingfa Chemicals Group Co. Ltd.Shandong Xinhua Pharmaceutical Company LimitedJiangsu Sopo (Group) Co. Ltd.Mitsubishi Gas Chemical Company Inc.Zhejiang Juhua Co. Ltd.Hebei Jinlong Chemical Co. Ltd.Tianjin Bohai Chemical Industry Group Co. Ltd.+2 more
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Most popular
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Hexamethylenetetramine (HMTA) (CAS 100-97-0) Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
or continue with your email
Your report is ready to access
Hexamethylenetetramine (HMTA) (CAS 100-97-0) Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Chemicals and Materials · scroll →Hexamethyleneimine Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportHexamethylene-Bis-Triacetone Diamine Market
Market size, share, segmentation and regional forecast.
$5.2B market · 2025 base year
View reportHexamethyldisilazane (HMDS) Market
Market size, share, segmentation and regional forecast.
$2.1B market · 2025 base year
View reportHexamethyldisilazane for Semiconductors Market
Market size, share, segmentation and regional forecast.
$3.9B market · 2025 base year
View reportHexamethyldisilazane for Lithium Battery Electrolyte Market
Market size, share, segmentation and regional forecast.
$4.3B market · 2025 base year
View reportγ-hexalactone Market
Market size, share, segmentation and regional forecast.
$5.5B market · 2025 base year
View reportHexakis-(6-Mercapto-6-Deoxy)-Beta-Cyclodextrin Market
Market size, share, segmentation and regional forecast.
$876M market · 2025 base year
View reportHexahydropthalic Anhydride (HHPA) Market
Market size, share, segmentation and regional forecast.
$531M market · 2025 base year
View reportHexagon Twist Net Market
Market size, share, segmentation and regional forecast.
$1.1B market · 2025 base year
View reportHexagonal Wire Mesh Market
Market size, share, segmentation and regional forecast.
$425M market · 2025 base year
View reportHexagonal Seal Tank Market
Market size, share, segmentation and regional forecast.
$312M market · 2025 base year
View reportHexagonal Boron Nitride Thermal Filler Market
Market size, share, segmentation and regional forecast.
$1.7B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
WinnerVMR Custom Report
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
Off-the-shelf PDF
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
600,000+source studies indexed
100%analyst-reviewed
Every figuresource-cited & traceable
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy
Questions, answered
How is the research actually conducted?
Every report is compiled from VMR’s continuously-updated intelligence across 600,000+ source studies - primary interviews, company filings, trade data, and government & industry databases. Figures are triangulated across multiple credible sources, then reviewed by a research analyst before your report is delivered.
What exactly do I get inside the report?
A full multi-chapter study: market definition & methodology, executive summary, market outlook (drivers, restraints, trends, Porter’s Five Forces), segment deep-dives, regional & country breakdowns, competitive landscape, and a full profile for every company you select - with interactive charts and data tables throughout.
How accurate are the numbers, and can I trust them?
Market sizing is reconciled across leading sources (Gartner, BCG, MarketsandMarkets, government bodies and more), with outliers removed and a confidence-graded median used for the base year. Every figure is source-cited and traceable to its origin, and an analyst validates the model before delivery.
Can I customise the chapters, regions and companies?
Yes. Choose exactly the chapters, regions and countries, and the companies you want benchmarked before you build - then adjust your selection and recompile anytime from your account. You only pay for the scope you need.
What formats do I receive, and is the data editable?
Every report is readable online in full. Downloadable formats are available as optional $99 add-ons: a formatted PDF and a fully editable XLSX containing all underlying data tables - so you can re-chart, re-model, or drop any figure straight into your own deck.